Provides the broadest coverage of pneumococcal serotypes available as a conjugate vaccine
In June 2023, ACIP recommended PCV20 for
Routine childhood vaccination (4 dose series for children 2-23 months old)
Vaccination in children age2-18 years with underlying medical conditions
Catch up vaccination
PCV20 is currently formulary and used for adult vaccination, with the updatedindications from ACIP it will be available for use in pediatric patients as well
Storage, Monitoring and Handing of Refrigerated or Frozen Medications and Vaccines: See Policy 916.3910
Current VIS: CDC Vaccine Information Sheet (PCV13)